Immune checkpoint inhibitor combinations-current and emerging strategies.
Saved in:
| Title: | Immune checkpoint inhibitor combinations-current and emerging strategies. |
|---|---|
| Authors: | Walsh RJ; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore., Sundar R; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.; Singapore Gastric Cancer Consortium, Singapore, Singapore., Lim JSJ; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore. csilsjj@nus.edu.sg.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. csilsjj@nus.edu.sg.; Cancer Science Institute, Singapore, National University of Singapore, Singapore, Singapore. csilsjj@nus.edu.sg. |
| Source: | British journal of cancer [Br J Cancer] 2023 Apr; Vol. 128 (8), pp. 1415-1417. Date of Electronic Publication: 2023 Feb 06. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
